je.st
news
Clot risk in Lilly lung-cancer drug raises FDA concerns
2015-07-07 21:33:35| Biotech - Topix.net
Eli Lilly and Co.' s experimental lung cancer drug has raised concerns with U.S. regulators that it may increase patients' risk of suffering potentially deadly blood clots.
Tags: risk
drug
concerns
raises
Category:Biotechnology and Pharmaceuticals
Latest from this category |
All news |
||||||||||||||||||||
|
|